Healthcare consumption after a change in health insurance coverage: a French quasi-natural experiment

Health Economics Review
Christine Sevilla-DedieuAlain Paraponaris

Abstract

Compared with the number of studies performed in the United States, few studies have been conducted on the link between health insurance and healthcare consumption in Europe, likely because most European countries have compulsory national health insurance (NHI) or a national health service (NHS). Recently, a major French private insurer, offering voluntary complementary coverage in addition to the compulsory NHI, replaced its single standard package with a range of offers from basic coverage (BC) to extended coverage (EC), providing a quasi-natural experiment to test theoretical assumptions about consumption patterns. Reimbursement claim data from 85,541 insurees were analysed from 2009 to 2018. Insurees who opted for EC were matched to those still covered by BC with similar characteristics. Difference-in-differences (DiD) models were used to compare both the monetary value and physical quantities of healthcare consumption before and after the change in coverage. As expected, the DiD models revealed a strongly significant, though transitory (mainly during the first year), increase after the change in coverage for EC insurees, particularly for costly care such as dental prostheses and spectacles. Surprisingly, consumption seemed...Continue Reading

References

May 1, 1985·The Journal of the American Dental Association·H BailitK Lohr
Jun 1, 1985·The Journal of the American Dental Association·W G ManningJ P Newhouse
Dec 8, 1983·The New England Journal of Medicine·R H BrookJ P Newhouse
Dec 8, 1997·Journal of Health Economics·S H LongJ Rodgers
Nov 5, 1988·Journal of Health Economics·E B Keeler, J E Rolph
Nov 5, 1988·Journal of Health Economics·E B KeelerK B Wells
Apr 10, 2003·Journal of Health Economics·Claudio Sapelli, Bernardita Vial
Jul 20, 2004·Health Economics·Thomas C BuchmuellerMarc Perronnin
Nov 11, 2006·Journal of Health Economics·David C Grabowski, Jonathan Gruber
Dec 17, 2008·The American Economic Review·David CardNicole Maestas
Nov 26, 2010·The American Economic Review·Amitabh ChandraRobin McKnight
Jan 8, 2013·The Quarterly Journal of Economics·Amy FinkelsteinUNKNOWN Oregon Health Study Group
Feb 5, 2015·Health Economics·Michael GerfinChristian Schmid
May 9, 2015·The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care·William B WeeksAlain Paraponaris
Oct 10, 2015·Health Economics·Stefan Boes, Michael Gerfin
Jan 9, 2016·Social Science & Medicine·H DickeyA Zangelidis
May 11, 2016·Health Economics·Brigitte Dormont, Mathilde Péron
Aug 2, 2016·Health Policy·Niklas Jakobsson, Mikael Svensson
Feb 7, 2017·Applied Health Economics and Health Policy·Lindsey WoodworthJames F Holmes
Mar 24, 2017·Social Science & Medicine·Anne Nolan, Richard Layte
May 30, 2017·Lancet·Barbara Casassus
Aug 5, 2017·The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care·Timo R Lambregts, René C J A van Vliet
Mar 20, 2018·Applied Health Economics and Health Policy·Pilar García-GómezJaume Puig-Junoy
Apr 18, 2018·Health Economics·Camilla Beck Olsen, Hans Olav Melberg
Apr 21, 2018·Social Science & Medicine·Mari Magnussen Landsem, Jon Magnussen

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.